MedTrace Logo

Early Recurrence After Surgery for Pancreatic Cancer

NCT07241676 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-11-21

No results posted yet for this study

Summary

The goal of this observational study is to learn about early recurrence after curative-intent surgery for pancreatic cancer. The main questions it aims to answer are:

* How often does early recurrence (within 12 months after surgery) occur?
* When does it happen, and at which anatomical sites (liver, lung, local, peritoneum)?
* How is recurrence detected (imaging or tumor markers)?

Adults with histologically confirmed pancreatic ductal adenocarcinoma who undergo curative-intent resection without distant metastases will be enrolled. Participants will be followed according to routine clinical care at each hospital, typically with imaging and CA19-9 blood tests. No study-specific interventions are required.

Conditions

  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • Recurrent Pancreatic Adenocarcinoma

Interventions

PROCEDURE

Curative-intent resection (R0, R1)

Standard-of-care surgical resection for pancreatic ductal adenocarcinoma, as determined by the multidisciplinary team. No study-specific interventions are mandated.

Sponsors & Collaborators

  • Azienda Ospedaliera di Padova

    lead OTHER

Principal Investigators

  • Giovanni Marchegiani, MD PhD · University of Padova

  • Giampaolo Perri, MD PhD · University of Padova

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-23
Primary Completion
2026-09-30
Completion
2028-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07241676 on ClinicalTrials.gov